Looking to implement or upgrade MilliporeSigma BioContinuum?
Schedule a Meeting
Continuous Bioprocessing

MilliporeSigma BioContinuum

Continuous bioprocessing platform transforming scalable, flexible biopharmaceutical manufacturing

Schedule a Meeting
Category
Software
Ideal For
Biopharmaceutical Manufacturers
Deployment
On-premise / Hybrid
Integrations
None+ Apps
Security
Validated process controls, data integrity monitoring, audit trails, role-based access
API Access
Yes - enables integration with laboratory information systems and manufacturing execution systems

About MilliporeSigma BioContinuum

The MilliporeSigma BioContinuum Platform is a continuous bioprocessing solution designed to revolutionize biopharmaceutical manufacturing across monoclonal antibodies (mAbs), cell therapies, and gene therapies. The platform integrates single-use technologies, advanced automation, and real-time process monitoring to deliver scalability, operational flexibility, and uncompromised product quality. By transitioning from batch to continuous manufacturing, biopharmaceutical producers can achieve higher productivity, reduced capital expenditure, and improved regulatory compliance. AiDOOS enhances BioContinuum deployment through expert governance frameworks, seamless integration with existing manufacturing infrastructure, process optimization consulting, and scalability support across multiple production facilities. The platform's modular architecture supports customized workflows while maintaining validated pharmaceutical manufacturing standards.

Challenges It Solves

  • Batch processing limitations restrict production capacity and extend time-to-market for critical therapies
  • High capital costs and operational complexity of traditional bioreactor systems hinder manufacturing scalability
  • Quality variability and batch-to-batch inconsistencies compromise product efficacy and regulatory approval timelines
  • Difficulty integrating legacy systems with modern automation and real-time monitoring capabilities
  • Lengthy process validation and regulatory submissions delay commercialization

Proven Results

64
Increased production throughput with continuous manufacturing
48
Reduced capital expenditure through single-use technology
35
Accelerated regulatory approval and time-to-market

Key Features

Core capabilities at a glance

Continuous Bioprocessing Engine

Seamless transition from batch to continuous manufacturing workflows

3-5x higher productivity compared to traditional batch methods

Single-Use Technology Integration

Eliminates cross-contamination risks and reduces cleaning validation burden

90% reduction in facility downtime and cleaning operations

Real-Time Process Monitoring & Analytics

Advanced sensors and data analytics for continuous quality assurance

99.2% product consistency and enhanced regulatory compliance

Automated Control Systems

AI-driven process optimization and self-correcting algorithms

Reduces manual intervention by 75% and human error rates

Scalable Architecture

Modular design supporting multiple production scales and therapies

Deploy across R&D, pilot, and commercial manufacturing seamlessly

Integrated Data Management

Comprehensive digital twin and electronic batch records

Full FDA 21 CFR Part 11 compliance and audit readiness

Ready to implement MilliporeSigma BioContinuum for your organization?

Schedule a Meeting

Real-World Use Cases

See how organizations drive results

Monoclonal Antibody (mAb) Production
Enables continuous perfusion and fed-batch production of mAbs with superior titer and purity. Reduces batch cycle time from 14-21 days to 3-5 days while maintaining quality standards.
72
Doubled annual production capacity without facility expansion
Cell Therapy Manufacturing
Supports continuous cell culture and expansion workflows for CAR-T and stem cell therapies. Maintains cell viability and potency throughout extended bioprocessing campaigns.
58
Enhanced cell viability and reduced manufacturing costs per dose
Gene Therapy Vector Production
Optimizes continuous production of viral and non-viral vectors with consistent transduction efficiency. Integrates downstream purification for complete end-to-end manufacturing.
65
Improved vector titer and faster patient treatment initiation
Contract Manufacturing Operations (CMO)
Enables CMOs to support multiple biopharmaceutical clients with flexible, campaign-based continuous manufacturing. Reduces campaign setup time and improves equipment utilization.
81
Increased equipment throughput and client production reliability
Rapid Bioprocess Development
Accelerates process development from concept to GMP manufacturing validation. Integrated analytics enable quick protocol iteration and risk-based decision making.
54
Development cycles reduced from 18 months to 8 months

Integrations

Seamlessly connect with your tech ecosystem

S

Siemens SCADA/PLC Systems

Explore

Direct integration with industrial control systems for automated process parameter adjustment and real-time equipment feedback

S

Sartorius evonik Laboratory Information Systems (LIMS)

Explore

Seamless data exchange for sample tracking, assay results, and automated report generation

R

Roche/Genentech Manufacturing Execution Systems (MES)

Explore

Integration with MES platforms for batch tracking, resource scheduling, and production planning

H

Honeywell ProcessScape DCS

Explore

Distributed control system integration enabling comprehensive plant-wide process visibility and optimization

L

LabVIEW Data Acquisition

Explore

Native support for LabVIEW systems to enable custom analytics and advanced process control algorithms

O

Oracle/SAP ERP Systems

Explore

Integration with enterprise resource planning systems for cost tracking, inventory management, and financial reporting

A

Aspen Plus Process Simulation

Explore

Digital twin modeling for process optimization and scale-up validation prior to manufacturing

Implementation with AiDOOS

Outcome-based delivery with expert support

Outcome-Based

Pay for results, not hours

Milestone-Driven

Clear deliverables at each phase

Expert Network

Access to certified specialists

Implementation Timeline

1
Discover
Requirements & assessment
2
Integrate
Setup & data migration
3
Validate
Testing & security audit
4
Rollout
Deployment & training
5
Optimize
Performance tuning

See how it works for your team

Schedule a Meeting

Alternatives & Comparisons

Find the right fit for your needs

Capability MilliporeSigma BioContinuum LabWare LIMS Castor EDC TraceLink
Customization Excellent Excellent Excellent Excellent
Ease of Use Good Good Excellent Good
Enterprise Features Excellent Excellent Excellent Excellent
Pricing Fair Fair Good Fair
Integration Ecosystem Excellent Excellent Good Excellent
Mobile Experience Fair Good Good Good
AI & Analytics Excellent Good Good Good
Quick Setup Good Fair Excellent Fair

Similar Products

Explore related solutions

LabWare LIMS

LabWare LIMS

LabWare LIMS: Comprehensive Laboratory Information Management System for Streamlined Lab Operations…

Explore
Castor EDC

Castor EDC

Castor EDC is an advanced, cloud-based Electronic Data Capture (EDC) platform designed to simplify …

Explore
TraceLink

TraceLink

TraceLink: Ensuring Compliance and Visibility in Pharmaceutical Supply Chains TraceLink is a cloud-…

Explore

Frequently Asked Questions

What types of biopharmaceutical products can BioContinuum support?
BioContinuum supports monoclonal antibodies (mAbs), recombinant proteins, cell therapies (CAR-T, stem cells), gene therapy vectors, and vaccine production. The modular platform is customizable for diverse bioprocess applications.
How does BioContinuum reduce manufacturing costs compared to batch processing?
Continuous manufacturing reduces batch cycle times by 70-90%, eliminates facility downtime between batches, minimizes single-use consumable waste, and enables higher equipment utilization. Combined with AiDOOS optimization services, total cost of goods sold typically decreases 30-45%.
What is the typical implementation timeline for BioContinuum?
Initial deployment typically requires 6-12 months depending on existing infrastructure. AiDOOS accelerates implementation through pre-configured modules, change management support, and regulatory guidance, reducing time-to-production by 3-4 months.
How does BioContinuum ensure regulatory compliance?
The platform includes validated controls, comprehensive audit trails, electronic batch records with 21 CFR Part 11 compliance, and integrated quality monitoring. AiDOOS provides regulatory consulting to expedite FDA/EMA submissions and inspections.
Can BioContinuum integrate with existing manufacturing systems?
Yes. BioContinuum features open API architecture and supports integration with SCADA, LIMS, MES, and ERP systems. AiDOOS manages integration planning, data mapping, and system validation for seamless deployment.
What ongoing support does AiDOOS provide for BioContinuum?
AiDOOS offers process optimization consulting, advanced analytics services, regulatory compliance updates, scalability planning, and workforce training to maximize ROI and ensure continuous manufacturing excellence.